Sigal Charles Elliott
Related Filers (4)
- Adaptimmune Therapeutics PLC (11)
- Surface Oncology, Inc. (10)
- Vir Biotechnology, Inc. (9)
- ALNYLAM PHARMACEUTICALS, INC. (3)
- Show More ...
Ownership (33)
4
Friday, 9/8/2023
Surface Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/3/2023
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/24/2023
Vir Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/19/2023
ALNYLAM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/2/2023
Vir Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/9/2023
Vir Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Vir Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/24/2022
ALNYLAM PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities
4
Wednesday, 8/24/2022
ALNYLAM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 7/1/2022
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Surface Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/25/2022
Vir Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/2/2021
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/10/2021
Surface Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/25/2021
Vir Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 10/13/2020
Vir Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 7/14/2020
Vir Biotechnology, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 7/14/2020
Vir Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/1/2020
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Friday, 6/12/2020
Surface Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/3/2019
Surface Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/3/2019
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/2/2019
Surface Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/6/2019
Surface Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/5/2018
Surface Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/26/2018
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Monday, 4/23/2018
Surface Oncology, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 4/18/2018
Surface Oncology, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 7/3/2017
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Friday, 8/12/2016
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Thursday, 5/19/2016
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/18/2016
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
3
Monday, 1/4/2016
Adaptimmune Therapeutics PLC: Initial statement of beneficial ownership of securities